Peer-reviewed veterinary case report
Long-term high-dose prednisolone effects on Beagle dogs' adrenal
By Boretti, Felicitas S et al.·Published in BMC veterinary research·2025·Clinic for Small Animal Internal Medicine·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Effects of long-term high-dose prednisolone in Beagle dogs on structural and functional responses of the HPA Axis.
- Species:
- dog
Plain-English summary
Four healthy Beagle dogs were given high doses of prednisolone, a steroid medication, for over 200 days to see how it affected their adrenal glands and hormone levels. After about 150 days, all the dogs showed signs of excessive cortisol, which is often linked to steroid use. Tests revealed that their adrenal glands shrank significantly, but most dogs still had a normal response to hormone stimulation. By the end of the study, the dogs' adrenal glands began to recover in size, suggesting that the dosing schedule allowed for some recovery of adrenal function.
People also search for: Beagle dog prednisolone side effects · dog adrenal gland problems · high-dose steroids in dogs
Abstract
BACKGROUND: Long-term glucocorticoid administration can suppress the hypothalamic-pituitary-adrenal (HPA) axis, increasing the risk of adrenal insufficiency upon withdrawal, with an unpredictable recovery timeline. This study provides a standardized evaluation of a > 200-day prednisolone administration regimen in dogs by assessing its effect on HPA axis through adrenocorticotropic hormone (ACTH) stimulation tests, ACTH dynamics monitoring, and adrenal ultrasonography. Four healthy Beagle dogs received once-daily oral prednisolone from days 1–181 (median dose: 2 mg/kg for days 1–150; median dose: 0.25 mg/kg for days 151–181). From days 182–208, prednisolone (median dose: 0.25 mg/kg) was given on alternate days before discontinuation on day 209. RESULTS: All dogs developed clinical signs of hypercortisolism after 150 days of high-dose prednisolone administration. The ACTH stimulation test indicated a reduced cortisol response after 150 days of high-dose administration, though only one dog exhibited cortisol levels below 138 nmol/L. Unexpectedly, endogenous ACTH concentrations were significantly increased on day 150 but had returned to baseline levels by day 183. ACTH curves showed a short-lived suppression, with levels declining within 6 h of each prednisolone dose and rebounding to baseline by 12 h. Ultrasonography revealed significant adrenal downsizing by day 150, with a reduction in the maximal diameter of the caudal pole of both adrenal glands (left: 15–42%, right: 13–26%). By day 211, adrenal size had significantly re-increased compared to day 150. CONCLUSIONS: Prolonged, once-daily high-dose prednisolone administration caused overt clinical hypercortisolism and pronounced adrenal shrinkage in dogs; however, most retained a normal functional reserve despite these structural changes. The rapid normalization of ACTH and only mild reduction in cortisol responsiveness indicate that once-daily dosing may allow sufficient off-drug intervals to maintain near-intact HPA function. Nevertheless, the absence of a twice-daily comparison group limits any definitive conclusions about the role of dosing frequency in preventing severe HPA axis suppression.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/40696374/